Drugs / Phlai
last change Dec 2021 re-read 3 minutes ago

Phlai

Developed for
allergic rhinitis
Investigated by
Chulalongkorn University · Government Pharmaceutical Organization

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04182919 Jan 2020 → Dec 2021 allergic rhinitis Chulalongkorn University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Phlai ClinicalTrials.gov intervention name — accepted as the source's own label NCT04182919 ↗
Route Oral “Using orally in the evening everyday in 4 weeks” NCT04182919 ↗